Expertise in
3
conditions

Stefan Kasper

Essen, NW, DE 
Expertise in
3
conditions
Essen, NW, DE 

Overview

Stefan Kasper practices practicing medicine in Essen, Germany.

Mr. Kasper is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Cholangiocarcinoma (Bile Duct Cancer), PIK3CA-Related Overgrowth Spectrum, and Liver Embolization.

He is actively involved in clinical research, co-authoring 93 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Essen, NW, Germany
Other Locations
Heidelberg, BW, Germany
Germany
Duisburg, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Study of RAMucirumab in Combination With TAS102 vs. TAS102 Monotherapy in Chemotherapy Refractory Metastatic Colorectal Cancer Patients
A Phase III Study of RAMucirumab in Combination With TAS102 vs. TAS102 Monotherapy in Chemotherapy Refractory Metastatic Colorectal Cancer Patients
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Ph2, Randomized, Open-Label, Multicenter, Three-Arm Trial of Sym004 Versus Each of Its Component Futuximab and Modotuximab, in Patients With Chemotherapy-Refractory Metastatic Colorectal Carcinoma and Acquired Resistance to Anti-EGFR mAb
A Ph2, Randomized, Open-Label, Multicenter, Three-Arm Trial of Sym004 Versus Each of Its Component Futuximab and Modotuximab, in Patients With Chemotherapy-Refractory Metastatic Colorectal Carcinoma and Acquired Resistance to Anti-EGFR mAb
Enrollment Status: Terminated
Publish Date: September 28, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

93 Total Publications

Tumor-associated neutrophils and macrophages differentially affect T cell biology in the head and neck cancer tumor microenvironment.
Tumor-associated neutrophils and macrophages differentially affect T cell biology in the head and neck cancer tumor microenvironment.
Journal: Journal of leukocyte biology
Published: July 13, 2026

Frequently Asked Questions about Stefan Kasper

Is Stefan Kasper a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Stefan Kasper is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stefan Kasper participate in research or clinical trials?

Yes. Stefan Kasper has published 93 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Stefan Kasper's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kasper's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile